Reversal of tissue hypoxia by a single intraventricular dose of sodium nitroprusside in a patient with severe medically refractory cerebral vasospasm after subarachnoid haemorrhage

Journal of Neurology Neurosurgery and Psychiatry

Volumn 72, Issue 1, 2002, Pages 123-124

  Raabe, A ^a   Vatter, H ^a   Zimmermann, M ^a   Seifert, V ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NIMODIPINE; NITROPRUSSIDE SODIUM; PAPAVERINE; TIRILAZAD;

ADULT; ANGIOPLASTY; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; CASE REPORT; CLINICAL TRIAL; DRUG MECHANISM; GLASGOW COMA SCALE; HUMAN; HYPOXEMIA; LETTER; MALE; NEUROSURGERY; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; TISSUE OXYGENATION;

ADULT; HUMANS; HYPOXIA, BRAIN; INJECTIONS, INTRAVENTRICULAR; MALE; NITROPRUSSIDE; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 0036147115     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.72.1.123     Document Type: Letter

References (4)

1. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: Initial observations regarding the use of intraventricular sodium nitroprusside in humans
2. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America
3. Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans
4. Intrathecal sodium nitroprusside improves cerebral blood flow and oxygenation in refractory cerebral vasospasm and ischemia in humans